QIPT.TO - Earnings call transcript Q3 2024

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Thank you for standing by. This is the conference operator. Welcome to the Fiscal Third Quarter 2024 Results Conference Call for Quipt Home Medical Corp. [Operator Instructions]

We remind you that the remarks today will include forward-looking statements that are subject to important risks and uncertainties.

these the uncertainties, results bottom on reader see news information at advisory of more risks please and the release. For the company's statements. actual company's performance differ from The could these materially

the At call Executive this Greg Crawford. like point, to Officer, over Chairman and I'd to Chief turn

Gregory Crawford

My operator, Chairman call. and Medical. Officer Quipt is you, Chief on you and for and Home thank Executive joining Thank Greg today Crawford, us all the name the I'm of

me Officer. Joining is our Hardik Financial Chief today Mehta,

provide care health way solutions treat to their services providing Home home to Medical to leveraging diversified Quipt medical At effectively excellence services with a spectrum that full and ecosystem, needs. setting at States. respiratory patient-centric home technology-enabled in in commitment home best programs is patients company, of patients equipment suits our a United is a through the unwavering Quipt, across our clinical our equipment the in conjunction specialized clinical

strategy market sales end-to-end core touch Our key shop providing as durable solution points our with in an care serving respiratory a drives equipment to marketplace. complementary one-stop go-to-market medical products the penetration through

apnea setting. impacting respiratory and across This to to respiratory At Americans on of with States. COPD the patient for underpenetrated care XX this is approximately group commitment home for OSA for XX of the by needs in capitalize product the scale ongoing significantly population and need time, over care the a with we mix diseases. ongoing poised adults an significant our patient the of achieving, accounts our need United sleep target patients With care cardiovascular are pulmonary showcasing delivered to and million XX% our respiratory driven care aging serving market dedication are we expanding million

revenue we XX.X%. resulted $XX.X QX of core will of our fiscal call, reported on In XXXX, EBITDA growth and provide insights fiscal our in our and business quarter marking adjusted year-over-year million, a into XXXX This road of adjusted X.X% provide map. margin growth we performance, updates X.X%. increase strategic $XX representing On million, strategic third this EBITDA of

revenues prior compared the generated of XX% $XXX.X and an ended adjusted months XX.X% the period. $XX.X to to increase corresponding XXXX, million of to We of period million XX.X% increased EBITDA X compared June revenue for the for representing XX,

and Our the management scale consistency strategy on our profile. of effective margin focusing enabled economies generating in cost

growth the the the We fiscal sequential are challenges represented very X% faced seen in pleased sequential of X% revenue the growth QX. organic of in in organic sequential decline flat face the with fiscal quarter from year-to-date. a in the made progress and year-over-year improvement solid saw third This We quarter.

given absorbed Which of lease are the for of been rate impact providers X. other the engaged of relief XX-XX and withdrawal with We providing Medicare proud January the due end the Medicare members industry. as Change a agreement of in for capitated on geographies the certain to that Advantage of improvement cyber-attack the had Healthcare

to helped referral in real levels has anticipate return historic We and a patterns have growth to offering across organic product time, the time. mitigate strength in our our which in impact, observed we of

Turning sleep to our business.

to have the to any we impact relates emphasis on date. not GLP-Xs from GLP-Xs, seen continued negative it whatsoever As

We very strong. remain have for supply seen referral device is setups replacement and patterns consistent new

frequent or rates Additionally, OSA XX on very with showed the manufacturer patients more with XX GLP-X highlighting data and the are prescribe and patients recently an additional well for sleep $X.X In increase Moreover, more the GLP-Xs, order leading our resupply positive months. to over start not impact treatment therapy PAP likely compared those XX.X% on data we those saw performed to adherence their involving these X%. showed diagnosis shared million an quarter, of device XXX,XXX from resupply program

The demonstrates therapy. GLP-Xs to adhering a on both Positive and positive impact data Airway seeking Pressure are shared that having patients,

of for the of It diagnosed We have the for and the million a demand these sleep adults important with obstructive medications OSA. in XX is availability of OSA, U.S. XX to the the think rise remember to have apnea treatment of illness number in cases that moderate that million over a PAP in market the severe will rise therapy. to lead whom

this untreated. that adherence estimated allows technology. multiple patients and undiagnosed remain modern criteria total of Medicare cases patients extremely CPAP and XX% using meeting large approximately the tolerated it's market also is The modalities. of CPAP for for XX% OSA U.S. treatment for Furthermore, segment is addressable well with of of

as We and goals, believe, our performance complementary will health of entering positive health developments motivated based as on they real-time the system the work time. a care GLP-Xs their of be for early the over introduction sleep data towards serving more tailwind business patients our

providing this any to resolve to possible. As a are relates to quickly government information has doing it reached progress, as civil diligently wrong the investigative known matter time, continue working ongoing make the demand, that At conclusion as this occurred. and we not the CID, has as

and We in effective practices. confident compliance our have internal and remain in controls procedures place around billing

ensuring fiscal collections working the processing claims In outstanding working was we QX, short-term through Healthcare were on capital normalize impact the laser-focused cyber-attack, of of cash Change the prioritized. and

impact, growth to begin on ways we at of side to value. capital to our create other and this allocate continue look to move to we Now the as promote

have in months, seen opportunities To with evolve of would landscape stringent plenty M&A we fit over strategic the marketplace recent that our mandate. the effect, this

reasonable flexibility it scale as to Our to and manner synergistic growing, acquisitions relates pipeline deploy multiples. in is capital to building at we the committed are economically thoughtful a with

underscores a is Moreover, one believe to of significantly whole, sale we larger multiple, which undervalued recent as trading current than time. how of our the is this the environment relates it company M&A at as our our peers, higher

up us will activity of, to Additionally, for are pick to we marketplace opportunities and market dislocation lead advantage M&A share. in take growth occur anticipate that we will the the from to ready and organic

conservatively pursue drive that managing continue strong our stands long-term debt enabling our net value sheet, will and for a initiatives leveraging at X.X which conservative strategic balance us shareholders. we leverage and Finally, to

continue As our are establish, growth. consistent care our implement payer long-term patient confident to and in and we strong exceptional sustained deliver to achieve strategic strategy, alliances growth we ability

I'd With the to like discuss to results. that call over quarter commentary, financial hand third XXXX Hardik fiscal to our

Hardik Mehta

Greg. we XX, U.S. are financial Thanks, fiscal our quarter all dollars. financial third June months in On that ended representing the Wednesday values Please evening, X note announced results, XXXX. XXXX

some Here highlights. are key

or XXXX, XXXX, XXX,XXX the of X% The in XXXX, XXX,XXX increase and an unique XXXX. unique deliveries in company unique company's increased from in QX patients to XXX,XXX deliveries year-over-year setups QX to completed customer unique base QX in setups patients up solved XX.X%. XXX,XXX QX Compared

XX, company ended its months X use This includes setups of resupply which creates and technology a for intake months respiratory processes. continued XX, year-over-year. XXXX, June revenue XX.X%, the XXXX, XXXX increase or year-over-year. the fiscal XXX,XXX for Organic growth to was for in to X.X% centralized to of compared QX approximately XXX,XXX the compared QX XXXX, contributed Revenue an ended $XX X June representing million million X.X% for fiscal $XX.X X% increase

from revenue. or QX months was nine XX.X% to the approximately million and growth million XXXX $X.X QX $XXX.X of Adjusted million total $XX.X $XX.X be XX, XXXX. to margin XX% XX.X% EBITDA for fiscal XXXX or by margin the strong The year-over-year. EBITDA a a grew for fiscal is compared QX for million Revenues XX.X% an X.X% ended X%. to of contributed Organic increase representing revenues the continues XXXX. June XXXX, as or approximately XX, Recurring nine increased months ended of June

XXXX, a The an company months revenue XX, generated from nine the EBITDA adjusted nine ended XXXX, months increase June XX.X% ended represents from for the $XX.X increase the ended XX.X% XX, million This June XX% for of ended months XXXX. of June nine XXXX. XX, the nine June XX, for months

June Cash nine million flow ended XXXX, XXXX, for to was the an million of months continuing $XX.X ended the $XX.X for nine XX, compared X.X%. XX, June from operations increase months

X% normal QX Change collection of and fiscal resulting direct bad indirect the efforts. incident, in cybersecurity debt a increased to X% For due to from from diversion effects XXXX, the Healthcare expenses

X-months rental June transfers XXXX, line fixed serialized to for the levels. the old ending historical purchase experienced when deploy the ventilators patients for CapEx as our with was due June replace inventory to XX.X% of assets XXXX, new period XX, from the defined XX, higher trilogy CapEx fleet. equipment the in We on ended months equipment model of to we nine in

XXXX. months $XXX,XXX support Acquisitions related largest June Operating accounted $XXX,XXX the the XX, with incurred approximately XX, expenses months of ended increase was from in component. XX.X% XXXX, the fees three increase for increase for organic payroll CID. June professional growth ending to Remaining to and revenue an the of being three XX.X%, was

compared XXXX, XXXX, $XX.X $XX.X reported the XXXX. million availability on had available on The of as company to March million credit to delayed-draw credit $XX cash with available XX, million XX, of revolving company of loan as of $XX.X June term June facility pursuant the XX, million facility. and on total hand $XX.X million The

sheet adjusted a to net a with The maintains of conservative leverage debt balance company EBITDA X.Xx.

shareholders. steady the is long-term business maintaining capital made for us to our throughout while our this scale into prudent growth allows component A as with and confident are pleased sustained we to economically translate our that ongoing progress are We value will management strategy initiatives this quarter, our key approach of our efficiency.

we investment geared towards on is growth. ensuring focus make Our sustainable every is that

to on the built we flow have margin for leveraging resources so, place, the and our capabilities sheet, we far. stable By have generation. infrastructure is Our including are doing foundation able and operational long-term already more maximizing and strong so sales strength strategy resilient future in balance acceleration growth, we cash a build developed

our faced to and our of QX. produce from mitigating X.X% decline year-over-year flat proud sequentially. An temporary improvement of fiscal are the revenue seen headwinds volume QX from continued fiscal growth growing We team we overall in sequential to efforts with growth the

priority organic to annualized basis. Our XX% of remains an achieving X% on growth target on

revolver organic ratio X.Xx. Our prudent and availability and inorganic million featuring $XX.X sheet conservative positions rates in and a both growth interest higher pursue navigate exceptionally an cash opportunities to well of strategically us environment balance leverage of with

to strategically of are to cash the balanced commitment and positioned mix growth. debt demonstrating We disciplined our utilize

it significant fluctuations. working we do capital, any generally relates to As not working seasonal have capital

the our June created Healthcare our working from estimate incident the Change reduction nine cash capital has the during Healthcare capital needs. XXXX, Change cybersecurity $X ended XX, been a impact increased million. months However, We flow and working approximately in

impact higher working As currently have. it should continue our claims, collecting reduce we that mitigate we outstanding this capital and

our basis, go-forward business. this forward On as with expand X% We any anticipate our the acquisitions and free a to X% we prior payable. continue see continue price payments as service we this CapEx but following long-term debt going improving on payments, to objective scenario relating flow to all lease and baseline to cash of to

in confident ability are net of CapEx our flow grow our We inclusive needs. our to cash

our on flexibility focusing continued to shareholder maximize value to adhere to allocation strict operating to discipline and within will our continue drive ensures financial strategy value. business scale crucial disciplined we creating capital by leverage. investments the building Maintaining is our financial long-term This approach, we success, our

is known as International financials to our U.S. known financial for U.S. Standards, also Lastly, a Accepted XXXX prepared Generally the fourth quarter be fiscal GAAP. fiscal year XXXX, Accounting starting reminder, full Principles, and September under this our ending means IFRS, we with statements year our fiscal audited quarter Financial as Reporting transition will under This GAAP. from XXXX XX, our also results starting last reporting will of

Form be X, October applicable the SEC applicable to subject Form as disclosure will financial statements effective with XXXX, U.S. the current the and filing that reports means to on reports companies. company will and the XX-Q domestic and Form requirements file same company required be periodic also to as X-K. and reporting as well XX-K It on

operations to forward geography this our important to as peers the well looking United as all accounting align we States in as it our within standards believe the our comparability being are We the to industry. improving with is transition of

Greg. Thank you. And with call to back turn that the update, I'll

Gregory Crawford

Hardik. Thanks,

solid and various on of thoughtful scale leveraging adjusted our showcased and capital a profile our Our existing operating approach. economies yielded By consistent and demonstrating margin. a strategic EBITDA margin has have sustained across management we environments, infrastructure adaptable focus

success Our coupled solutions, and sustained comprehensive our range with of pivotal end-to-end diverse market product a mix expansion. respiratory is to

catalyst which key systems underpins and physician solidifies on long-term our market time our as growth, sales channels expansion strategy for a offices, volume such growth. Concentrating organic primary hospital position. our This drives remains and

growth central objectives only productivity, efficiency and is enhancing not focus efficiencies strategy organic Our investment long-term overall our and creating automating remain in outcomes. infrastructure, by operational processes markets nationwide. but in we to our supports operational reduce and aim we on competitive improve to our our also costs patient key agile This boost ensures

cash road organic map, emerging and strategic seize growth, to our focused well long-term margin opportunities. financial on as driving on generation at enhancing as flexibility we are retaining growth Looking flow

long-term We market are by committed positioning to in clinical leveraging organic respiratory unique driving our care. growth

of achieving for demand X% by expanding to goal services. underpinned XX% annualized the Our home-delivered growth is respiratory

an growth, expansion solutions sales driven apnea COPD market explore we This by an portfolio, markets. demand product our our this underpenetrated of aging broaden prevalence continuously population strategic comprehensive is sleep to support and opportunities market. new initiatives. To on and We focus product significant and penetrate cross-sell

efforts access key growth stronger through enhanced and payers care volume-based areas. providers relationships with targeted aims and to strategies Our drive health sales to geographic

supplies. glucose related an monitors, This and to patient represents to base offering has the increasing existing known SG&A without rollout the of a shown our results featuring CGMs early add significant value announced promising expanded initiative as market to include and Recently, also expenses. continuous diabetes we opportunity segment,

can By and unmet cross-sell a the offering equipment strengthens products care need, comprehensive relationships our established effectively. enhances addressing and understanding patient our an needs position new ecosystem. in product provider medical home move as deep of we leverage our This to

patient up the also diabetes with potential population existing diagnosed our complements X sleep highlighting patient synergistic well. XX% our apnea, individuals that clinical of indicates base diabetes expanded The research of portfolio. type have to

overall grow, achieving margin and flow, streamlining our Second, as and generation. enabling enhance we growth initiatives by are improvement invest we economies operations flow positive our margins us in aim and scale to cash to cost committed structure drive and cash to of we optimizing our continuous

to are promoting dedicated electronic industry. we adoption as also Furthermore, the of our known long-term E-prescribe prescribing within

outcomes. positions reduced of benefit increased numerous to the patient improve to commitment productivity, and us better compliance errors, adoption technologies Our advantages. its these well from Including

us with illustration higher make also not The program how but extending also benefits strategic rates automated Our synergies long-term a resupply us as as adherence a it in therapy, we helps another revenue which excellent well only It is resupply of recurring offers us technology. the cycle to all life acquisitions. platform growth, revenue patient. use when role we crucial organic plays driving margin achieve and compliance and significant patient

meet towards stringent Lastly, have ample a more are contributing successfully million allocate in conservative balance than candidates acquisition revenue. we allowing sheet acquisitions Since XX to ensure criteria. to synergistic committed to capital we flexibility, that $XXX maintaining us our XXXX, integrated

disciplined platform management, modest our Our our synergistic to strategy acquisition around bolster respiratory in to strategic enhances approach long-term opportunities support with capacity will invest generation strategy cash coupled leverage. net debt offering. centered our of in investments operating our and market that end-to-end go-to-market and This positive comprehensive expansion our objectives

investor valuation ambitions States throughout of with XXXX. roadshows the investors our to compared discuss we and includes On actively attending in front, fundamentals. capital interacting remainder conferences various United to markets the long-term our from and our growth are investor ongoing Canada This disconnect and the

and always, our continue shareholder to audience will to base. investor overall we As build work

want the than believe to again current peer opportunity to announcement fundamentals. potential upon ability very does note overall of Importantly, a organic higher industry M&A further on at developments occur, recent a reflect larger we our and valuation, of market to take I anticipate business our in growth sale multiple our we Based this dislocation historical which significantly not to are initiatives. confident large we seize place, likely our when the

growth a focus success. future, long-term on puts the position approach strong us synergistic along strategic with acquisitions, to methodical to our in Looking our organic for

operational strategy and utilize internal our developing is scalable dedication to Our to efficiencies. robust demonstrated by and company resources capacity a

to manage value as to providing not we to the environment shareholders strategy. commitment flexible our operational our capital allocation will stick waver and Our

of In sequential summary, to the in market fiscal improving model from our impact. resilience strength while and our the fiscal decline trend improvement shows in our QX platform the and seen the scaled business positioning, posed lingering underlying operational QX mitigate challenges revenue the of current

our well positioned opportunities continued expansion. are the we of and seize support further appreciate investors, the extremely We to for

entire once to continued for to want team chance for our tireless take their the support. work, again and their I thank Quipt stakeholders this Finally,

Operator

[Operator Instructions].

with question Genuity. is from Richard The first Close Canaccord

Richard Close

how growth curious year that sequential opportunity signed the you're for competitors? were the just given I'm quarter, capitation XX-XX fourth contracts last thinking by in about

Gregory Crawford

working Richard, withdrawal Advantage Med the of to the and Thanks, diligently that the decline that Yes. the anticipate XX-XX for are plan. in challenges with also the face and in question. then We overcome -- the the we in

to year see year grow here. volumes that in into the the of starting as We calendar half are back we -- our get

Richard Close

equipment I on the put but follow-up, you the just sequentially, slight setups metrics third metrics And what it resupply, and then was look the service in if growth the curious, of as here quarter growth improvement from a Okay. maybe second the quarter, patient was in the good a increased. at there we and obviously, think number up respiratory revenue, flat

anything there and Or for from but bump and don't quarter. deliveries revenue sequential goes all patient would that, that metrics you on be Is that see second reason the the what pricing? in up, really

Hardik Mehta

this Hardik. seeing XX-XX I guess card. is the you rate impact And Yes, are of the

rate. the product delivering essentially at doing it a lower same You're but

of that So lost. capitated that insurance is as a that as cumulative the we far definitely impact

a I abducted when say of think more is due -- margins. lot there a terms there to is abilities your depression you cross-selling source. would referral But with the that I sometimes contract in lose gets

a the XX-XX. the -- at towards that point it's So towards most would Medicare point, fact there then not -- mostly likely, a reimbursement some but also likely was that on rate similar I plans And would say contributed most impact. have cut

one. the really So that's

Richard Close

Okay.

occurred March little a than more the bit in quarter? what maybe just it's So XX-XX from

Hardik Mehta

happening Change everything guess. -- That the was the same think Healthcare and at The time. yes. I I

period taking it X-month results a as trying than a would point, a a as period X-months look of looks like otherwise operating than at a take X-month more, more been But at rather of management month guess, the kind X- kind it. I we at a for which we this at and a -- rather to there's quarters. have June ending So

Richard Close

Okay. And obviously, back cited then and just question, seemed to the my comments final metrics up. referral the I the on that I that appreciate patterns

years? a sort to Humana guess, to as can that we Is done about growth back level? we XX-XX target well and it X% the last think just shift? then And couple there you've then organic I the on lapping XX% out of pop Greg, the of matter that of a up

Gregory Crawford

Yes, of that absolutely. the in that two factors in that, it seen been by driven that Most withdrawal Humana. of those we've the XX-XX has in the and

that team, really kind we've and of to drive that sales our up continue to into the the -- also with territories. additional referrals So and in to had in to sales has areas and been pick in have throughout in that forward, other that expanding pivot revenue coverage that continuum then try that

Operator

Canaccord next Richard [Operator Instructions]. from The is question Close Genuity. with

Richard Close

I'll comments, & Owens with in likely Okay. one to Greg, is the another market and from picking of to share, Rotech terms Minor here. occur dislocation that the deal. respect up take With the

experience saw meaningful there. Just Do terms geographic to curious where of you and any some you have pickup in past occurred has you certain in can point that this markets?

Gregory Crawford

been kind if the and just make the there's we benefit years, flip to in happen and side we've with up say Yes, historically, that I have consolidation. dislocation, I'll that And too dislocation that stand think that of absolutely. that And when and market. and post on also the when does But lost seen when we've then we of business we've in M&A, seen over it acquisition. especially mean that's and had to that

Richard Close

on maybe XXX sequentially. here in That's I and over really going Okay. year-over-year up that quickly. guess to up going debt, just then the terms basis points it's bad of attributed helpful. maybe change And slightly

favorable, What X% are below moving bad pretty the on your guys' debt obviously, because thoughts level trend the was previously. down

about we bad debt. on thoughts just So think how should

Hardik Mehta

some it's might hasn't business see given would any believe or was. it for I the coming data so, have to material risk still Healthcare. There the long-term This overall maybe in of the be us quarter or elevated place. the mean see But it goal reimbursement so. back any fair integrity or where been -- we a part operations the Change I to of I it think the changes but to a kind of we X% change is quarter the in over Yes. next mean of or way taking bring we

quarters, of processes let hopefully, RCM it's deviations But to through and AR terms matter in, Change as the go are we related collect Again, and Healthcare the outstanding not on up there. hold just of So data come much from kind of outcomes, going a any baseline we there. baseline next how in the of as far the couple seeing

Operator

with from Justin Keywood The next question is Stifel.

Justin Keywood

if a I to it. level in forward sure near EBITDA Not missed assume term? the going margin good this Is

Hardik Mehta

say would revenue if mean, all kind from XX-plus certainly XXX% we I mean, I maintained of kind And the drop a our into flushed if kind of think of you margin. that, very has have despite part. or our most for I EBITDA the EBITDA of positively. of about it,

have revenue increased you This So very without the that, it, appreciate for said what support should margin cost. bring that the about to workforce EBITDA having margin if and to we done able of seems But are support back that stay. to a to have. where good like think having kind fixed if EBITDA an the you have operations

Justin Keywood

X%. year? then achievable conversion Is to something QX? more that the it free flow Or of be And Okay. target comment X% fiscal on will next the in cash that's into

Hardik Mehta

which it, little mean, I a flow which Healthcare all still expenses Change cash impacted out. ironed couple did we the affecting the that still there's mean -- hit a have will of where with bit with fact Change did quarters get -- that quite parts bit, legal our has is that that. a I goes of CID, moving is we

-- a all will is the I in what again, X% for that X% it. we've have achieved So that of say hoping we would and last quarters, of Or between see steady level actually, then X it been more we quarters. couple to out, will the next

Justin Keywood

valuation large that And a if that the Okay. That's multiple appropriate target targets of acquisition you smaller in then have the the the assuming industry that clear. any is for Quipt, level metrics size. point could And in on to there. are there's then acquire if you to peer, First, also at,

Gregory Crawford

Yes.

So I it as the think press referring that that that EBITDA, the in and the according to there. relates deal that was that multiple and to to to release that X.X% were we

in historically tuck-ins. us one for that companies and will opportunity that's future, we have seemed that or to see where And then So historically the we've to and in underspace, which anything XX of multiple in a we in will that information is any that further turns don't in any the say other lot company synergies, can and on acquired still two we that. X% this But range acquire and we've synergies. think where those that that's that the be. We where be prior million of is X% to to got

that ultimately, that. think building it's all we about So value in in that long-term

even we and trading our So come out X.Xx. at probably if than is now less stock right that

still going that, is our long-term So we're creating end to in value goal. which up

Justin Keywood

occur the that something Is that M&A? year? this calendar timing What's for could potential

Gregory Crawford

first to are part of the that after been working pivoting pipeline, the and we've challenges in We're diligently the and that. surprised in around in with year able actually that pipeline we've that's the that that we quite Yes. the and faced reinvigorate in

on deals them possible. So as be and as quick closing diligently we'll working

Justin Keywood

on There a question. good X.X. mention more one just at a was balance then sheet the And leverage of pretty

rate comfort as somewhat What's as range interest bringing up that still considering the high leverage far rates?

Hardik Mehta

Yes.

went So can we easily. to if I mean, survive still company the X mathematically, up

think can it would be can with comes blink in, maybe a is, I mean of eye, I So Maybe, that It comfort an stretch be, further? a little that we? not.

X% you our there's that flow at range can defined cash free as think come the way, if are it perspective within go the year-to-date, look definitely to intend X%. as three, to quarter flow one will free that on do company, part is you the we that right for don't By the strong. from we We're we X% as of that asked earlier, cash seeking availability even up now credit still around agreement, by though the that. clarification out I to had So but

think year-to-date we still But I for the number, are that in range.

just So that. clarify wanted to I

Operator

[Operator Venton from next with Financial. question Instructions]. The is Quenneville Stefan

Stefan Quenneville

the just GLP-X a question I impact. have on of sort

not seeing starts operational any all CPAP your and that. you're said impact on You

the apnea, GLP-Xs it's are is requiring for seeing being side the they're being to Are Given that with prescribed anything the sleep typically prescribed GLP-Xs off-label insurance first prescribed are currently. if being given start just on before CPAP you patients obviously both? sort CPAP? And are less results Or good perspective? you CPAP Xs. get with keep any see it's you a rather are lot of they expensive trends for to there GLP than on someone -- reimbursing Just insurance from

Gregory Crawford

we're the but different in not asking question That's seeing that that, have in pharmacy-based around that. that's not and but been yet, peers either a good trend yet. not really actually Yes. We're presented been

in think that have had for the out device in was largest released that, by that -- CPAP, you when look seen the most XX% it, recipients they the that they XXX,XXX study is that they've a that study I with recent in manufacturer increase.

prescribed that for devices and that that's one that at versus And a and is patient on being GLP-X not.

I taken in that need care healthier, driving of not they order get they're happier live into of think life. care really weight the just everything to more going a take in And to They're kind is GLP-X that ultimately, care system. to So is this their health to that of care problem. of going people indicates take

Operator

Crawford closing concludes remarks. question-and-answer over This today's session. to I'd for Mr. like the turn any back conference to

Gregory Crawford

operator, you, and thank participation all today. Thank you your for

web the can call posting be of this on updated deck. at investor you a us will always, where also transcript find As quipthomemedical.com, our and we

call. site, products you, this the some day. of you and also on great On have a can the developments Thank view discussed exciting and

Operator

to close brings call. conference This of a today's

You Thank your and you have day. may lines. disconnect participating, for a pleasant

Quipt Home Medical (QIPT) 15 Aug 242024 Q3 Earnings call transcript